Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex

The lipid nanoparticle (LNP)-formulated mRNA vaccines BNT162b2 and mRNA-1273 are a widely adopted multi vaccination public health strategy to manage the COVID-19 pandemic. Clinical trial data has described the immunogenicity of the vaccine, albeit within a limited study time frame. Here, we use a wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Korosec, Chapin S., Farhang-Sardroodi, Suzan, Dick, David W., Gholami, Sameneh, Ghaemi, Mohammad Sajjad, Moyles, Iain R., Craig, Morgan, Ooi, Hsu Kiang, Heffernan, Jane M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732004/
https://www.ncbi.nlm.nih.gov/pubmed/36481777
http://dx.doi.org/10.1038/s41598-022-25134-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732004/
https://www.ncbi.nlm.nih.gov/pubmed/36481777
http://dx.doi.org/10.1038/s41598-022-25134-0

Ejemplares similares